Upon its approval in 2017, Novartis priced tisa-cel at $475,000 – a number that many healthcare systems and payers balked at initially – and in 2023 the price increased to $508,250.

The designations demonstrate the highest level of commitment to quality healthcare PORTLAND, Ore., May 3, 2022 /PRNewswire/ -- AllMed Healthcare Management, Inc., a leading provider of utilization ...

Post this on X (formerly Twitter): .@jfrog unveils new integration with @datadoghq for greater cloud-native app utilization visibility and #security. Learn more: https://jfrog.co/4bFcpCL # ...

Discover how CCUS-EOR technology can enhance oil recovery while reducing carbon emissions. A new study in Engineering ...

A comprehensive utilization index identifies industry-wide over-utilization and common culprits. The Change Healthcare 2021 Laboratory Ordering Utilization Index is based on an internal analysis ...

New research indicates comprehensiveness in primary care could be just as significant as care access and coordination. Patients who receive comprehensive primary care have lower Medicare ...

The program leverages a comprehensive utilization management (UM) solution to shift utilization to the lower-cost biosimilar versions of infliximab, which is used to treat autoimmune conditions ...